JNC Medical shareholder divests stake in the company

01 December 2020

Effective December 1, 2020, Christopher Mulvanny, a principal shareholder of JNC Medical Inc., completed the sale of his stake in the company to 9888055 Canada Inc. and another individual.



JNC Medical Inc., headquartered in Ottawa, is a distribution consulting firm specializing in facilitating access to innovative medical device technologies and solutions.

Lorraine Mastersmith and Martin Roy of Gowling WLG advised Mr. Mulvanny in this transaction.


NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.